Miller Value Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,101,735
| Closed | -$36.7M | – | 116 |
|
|
2021
Q1 | $36.7M | Sell |
4,101,735
-94,365
| -2% | -$845K | 0.95% | 39 |
|
|
2020
Q4 | $48.4M | Sell |
4,196,100
-1,078,339
| -20% | -$12.4M | 1.47% | 31 |
|
|
2020
Q3 | $54.9M | Buy |
5,274,439
+78,889
| +2% | +$821K | 1.97% | 16 |
|
|
2020
Q2 | $68.3M | Buy |
5,195,550
+956,081
| +23% | +$12.6M | 3.03% | 8 |
|
|
2020
Q1 | $33.4M | Sell |
4,239,469
-693,406
| -14% | -$5.46M | 2.15% | 23 |
|
|
2019
Q4 | $102M | Sell |
4,932,875
-282,935
| -5% | -$5.86M | 3.62% | 5 |
|
|
2019
Q3 | $71.5M | Buy |
5,215,810
+363,350
| +7% | +$4.98M | 2.87% | 11 |
|
|
2019
Q2 | $59.7M | Buy |
4,852,460
+742,740
| +18% | +$9.14M | 2.27% | 21 |
|
|
2019
Q1 | $51.3M | Buy |
4,109,720
+996,330
| +32% | +$12.4M | 2.03% | 25 |
|
|
2018
Q4 | $35.2M | Buy |
3,113,390
+232,190
| +8% | +$2.63M | 1.6% | 29 |
|
|
2018
Q3 | $53.9M | Buy |
2,881,200
+227,425
| +9% | +$4.26M | 1.74% | 28 |
|
|
2018
Q2 | $68.6M | Sell |
2,653,775
-16,125
| -0.6% | -$417K | 2.56% | 12 |
|
|
2018
Q1 | $59.8M | Sell |
2,669,900
-14,600
| -0.5% | -$327K | 2.49% | 16 |
|
|
2017
Q4 | $67.2M | Buy |
2,684,500
+1,503,175
| +127% | +$37.6M | 2.86% | 13 |
|
|
2017
Q3 | $28.6M | Buy |
1,181,325
+653,525
| +124% | +$15.8M | 1.23% | 28 |
|
|
2017
Q2 | $10.7M | Buy |
+527,800
| New | +$10.7M | 0.43% | 33 |
|